{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,16]],"date-time":"2026-11-16T19:03:02Z","timestamp":1794855782456,"version":"4.9.1"},"reference-count":58,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"4","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":["Continuum"],"published-print":{"date-parts":[[2016,8]]},"DOI":"10.1212\/con.0000000000000348","type":"journal-article","created":{"date-parts":[[2016,8,9]],"date-time":"2016-08-09T12:49:40Z","timestamp":1470746980000},"page":"1117-1142","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":110,"title":["Diagnostic Approach to Atypical Parkinsonian Syndromes"],"prefix":"10.1212","volume":"22","author":[{"given":"Nikolaus R.","family":"McFarland","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"e_1_3_1_2_2","volume-title":"Neurology in clinical practice","author":"Jankovic J","year":"2008","unstructured":"Jankovic J Lang AE. Movement disorders: diagnosis and assessment. In: Bradley WG Daroff RB Fenichel GM Jankovic J, eds. Neurology in clinical practice. 5th edition. Philadelphia, PA: Saunders; 2008.","edition":"5"},{"key":"e_1_3_1_3_2","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1136\/jnnp.52.Suppl.78","article-title":"Multiple system atrophy\u2014the nature of the beast","author":"Quinn N","year":"1989","unstructured":"Quinn N. Multiple system atrophy\u2014the nature of the beast. J Neurol Neurosurg Psychiatry 1989;(suppl):78\u201389. doi:10.1136\/jnnp.52.Suppl.78.","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"e_1_3_1_4_2","first-page":"25","article-title":"Supranuclear ophthalmoplegia, pseudobulbar palsy, nuchal dystonia and dementia. A clinical report on eight cases of \u201cheterogenous system degeneration.\u201d","volume":"88","author":"Richardson JC","year":"1963","unstructured":"Richardson JC Steele J Olszewski J. Supranuclear ophthalmoplegia, pseudobulbar palsy, nuchal dystonia and dementia. A clinical report on eight cases of \u201cheterogenous system degeneration.\u201d Trans Am Neurol Assoc 1963;88:25\u201329.","journal-title":"Trans Am Neurol Assoc"},{"issue":"4","key":"e_1_3_1_5_2","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1136\/jnnp.2005.074070","article-title":"Predictors of falls and fractures in bradykinetic rigid syndromes: a retrospective study","volume":"77","author":"Williams DR","year":"2006","unstructured":"Williams DR Watt HC Lees AJ. Predictors of falls and fractures in bradykinetic rigid syndromes: a retrospective study. J Neurol Neurosurg Psychiatry 2006;77(4):468\u2013473. doi:10.1136\/jnnp.2005.074070.","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"1","key":"e_1_3_1_6_2","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/j.jns.2010.08.010","article-title":"Vertical wrinkling of the forehead or procerus sign in progressive supranuclear palsy","volume":"298","author":"Batla A","year":"2010","unstructured":"Batla A Nehru R Vijay T. Vertical wrinkling of the forehead or procerus sign in progressive supranuclear palsy. J Neurol Sci 2010;298(1-2):148\u2013149. doi:10.1016\/j.jns.2010.08.010.","journal-title":"J Neurol Sci"},{"issue":"5","key":"e_1_3_1_7_2","doi-asserted-by":"crossref","first-page":"1184","DOI":"10.1212\/WNL.47.5.1184","article-title":"Neuropsychiatric aspects of progressive supranuclear palsy","volume":"47","author":"Litvan I","year":"1996","unstructured":"Litvan I Mega MS Cummings JL Fairbanks L. Neuropsychiatric aspects of progressive supranuclear palsy. Neurology 1996;47(5):1184\u20131189. doi:10.1212\/WNL.47.5.1184.","journal-title":"Neurology"},{"issue":"8","key":"e_1_3_1_8_2","doi-asserted-by":"crossref","first-page":"1382","DOI":"10.1007\/s00415-010-5550-3","article-title":"Pseudobulbar affect: prevalence and quality of life impact in movement disorders","volume":"257","author":"Strowd RE","year":"2010","unstructured":"Strowd RE Cartwright MS Okun MS Pseudobulbar affect: prevalence and quality of life impact in movement disorders. J Neurol 2010;257(8):1382\u20131387. doi:10.1007\/s00415-010-5550-3.","journal-title":"J Neurol"},{"issue":"1","key":"e_1_3_1_9_2","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1097\/00005072-199601000-00010","article-title":"Validity and reliability of the preliminary NINDS neuropathologic criteria for progressive supranuclear palsy and related disorders","volume":"55","author":"Litvan I","year":"1996","unstructured":"Litvan I Hauw JJ Bartko JJ Validity and reliability of the preliminary NINDS neuropathologic criteria for progressive supranuclear palsy and related disorders. J Neuropathol Exp Neurol 1996;55(1):97\u2013105.","journal-title":"J Neuropathol Exp Neurol"},{"issue":"9","key":"e_1_3_1_10_2","doi-asserted-by":"crossref","first-page":"1312","DOI":"10.1002\/mds.22583","article-title":"Cerebellar involvement in progressive supranuclear palsy: a clinicopathological study","volume":"24","author":"Kanazawa M","year":"2009","unstructured":"Kanazawa M Shimohata T Toyoshima Y Cerebellar involvement in progressive supranuclear palsy: a clinicopathological study. Mov Disord 2009;24(9):1312\u20131318. doi:10.1002\/mds.22583.","journal-title":"Mov Disord"},{"issue":"14","key":"e_1_3_1_11_2","doi-asserted-by":"crossref","first-page":"1758","DOI":"10.1002\/mds.26054","article-title":"The phenotypic spectrum of progressive supranuclear palsy: a retrospective multicenter study of 100 definite cases","volume":"29","author":"Respondek G","year":"2014","unstructured":"Respondek G Stamelou M Kurz C The phenotypic spectrum of progressive supranuclear palsy: a retrospective multicenter study of 100 definite cases. Mov Disord 2014;29(14):1758\u20131766. doi:10.1002\/mds.26054.","journal-title":"Mov Disord"},{"issue":"6","key":"e_1_3_1_12_2","doi-asserted-by":"crossref","first-page":"1247","DOI":"10.1093\/brain\/awh488","article-title":"Characteristics of two distinct clinical phenotypes in pathologically proven progressive supranuclear palsy: Richardson\u2019s syndrome and PSP-parkinsonism","volume":"128","author":"Williams DR","year":"2005","unstructured":"Williams DR de Silva R Paviour DC Characteristics of two distinct clinical phenotypes in pathologically proven progressive supranuclear palsy: Richardson\u2019s syndrome and PSP-parkinsonism. Brain 2005;128(pt 6):1247\u20131258. doi:10.1093\/brain\/awh488.","journal-title":"Brain"},{"issue":"15","key":"e_1_3_1_13_2","doi-asserted-by":"crossref","first-page":"2235","DOI":"10.1002\/mds.21698","article-title":"Pure akinesia with gait freezing: a third clinical phenotype of progressive supranuclear palsy","volume":"22","author":"Williams DR","year":"2007","unstructured":"Williams DR Holton JL Strand K Pure akinesia with gait freezing: a third clinical phenotype of progressive supranuclear palsy. Mov Disord 2007;22(15):2235\u20132241. doi:10.1002\/mds.21698.","journal-title":"Mov Disord"},{"issue":"3","key":"e_1_3_1_14_2","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1016\/S1474-4422(09)70042-0","article-title":"Progressive supranuclear palsy: clinicopathological concepts and diagnostic challenges","volume":"8","author":"Williams DR","year":"2009","unstructured":"Williams DR Lees AJ. Progressive supranuclear palsy: clinicopathological concepts and diagnostic challenges. Lancet Neurol 2009;8(3):270\u2013279. doi:10.1016\/S1474-4422(09)70042-0.","journal-title":"Lancet Neurol"},{"issue":"6","key":"e_1_3_1_15_2","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1080\/13554794.2011.627345","article-title":"Autopsy-proven progressive supranuclear palsy presenting as behavioral variant frontotemporal dementia","volume":"18","author":"Hassan A","year":"2011","unstructured":"Hassan A Parisi JE Josephs KA. Autopsy-proven progressive supranuclear palsy presenting as behavioral variant frontotemporal dementia. Neurocase 2011;18(6):478\u2013488. doi:10.1080\/13554794.2011.627345.","journal-title":"Neurocase"},{"issue":"2","key":"e_1_3_1_16_2","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1212\/WNL.0b013e3181a92bcc","article-title":"Familial aggregation of parkinsonism in progressive supranuclear palsy","volume":"73","author":"Donker Kaat L","year":"2009","unstructured":"Donker Kaat L Boon AJ Azmani A Familial aggregation of parkinsonism in progressive supranuclear palsy. Neurology 2009;73(2):98\u2013105. doi:10.1212\/WNL.0b013e3181a92bcc.","journal-title":"Neurology"},{"issue":"1","key":"e_1_3_1_17_2","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.jns.2013.03.015","article-title":"Atypical progressive supranuclear palsy presenting as primary lateral sclerosis","volume":"329","author":"King A","year":"2013","unstructured":"King A Curran O Al-Sarraj S. Atypical progressive supranuclear palsy presenting as primary lateral sclerosis. J Neurol Sci 2013;329(1\u20132):69. doi:10.1016\/j.jns.2013.03.015.","journal-title":"J Neurol Sci"},{"issue":"1","key":"e_1_3_1_18_2","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/j.jns.2012.09.005","article-title":"Progressive supranuclear palsy presenting as primary lateral sclerosis but lacking parkinsonism, gaze palsy, aphasia, or dementia","volume":"323","author":"Nagao S","year":"2012","unstructured":"Nagao S Yokota O Nanba R Progressive supranuclear palsy presenting as primary lateral sclerosis but lacking parkinsonism, gaze palsy, aphasia, or dementia. J Neurol Sci 2012;323(1\u20132):147\u2013153. doi:10.1016\/j.jns.2012.09.005.","journal-title":"J Neurol Sci"},{"issue":"4","key":"e_1_3_1_19_2","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1097\/WCO.0b013e32833be924","article-title":"Neuropathology of variants of progressive supranuclear palsy","volume":"23","author":"Dickson DW","year":"2010","unstructured":"Dickson DW Ahmed Z Algom AA Neuropathology of variants of progressive supranuclear palsy. Curr Opin Neurol 2010;23(4):394\u2013400. doi:10.1097\/WCO.0b013e32833be924.","journal-title":"Curr Opin Neurol"},{"issue":"8","key":"e_1_3_1_20_2","doi-asserted-by":"crossref","first-page":"1104","DOI":"10.1002\/mds.23045","article-title":"Cerebellar involvement in progressive supranuclear palsy","volume":"25","author":"Jellinger K","year":"2010","unstructured":"Jellinger K. Cerebellar involvement in progressive supranuclear palsy. Mov Disord 2010;25(8):1104\u20131105. doi:10.1002\/mds.23045.","journal-title":"Mov Disord"},{"issue":"6","key":"e_1_3_1_21_2","doi-asserted-by":"crossref","first-page":"1578","DOI":"10.1093\/brain\/awq115","article-title":"Rational therapeutic approaches to progressive supranuclear palsy","volume":"133","author":"Stamelou M","year":"2010","unstructured":"Stamelou M de Silva R Arias- Carri\u00f3n O Rational therapeutic approaches to progressive supranuclear palsy. Brain 2010;133(pt 6):1578\u20131590. doi:10.1093\/brain\/awq115.","journal-title":"Brain"},{"issue":"7","key":"e_1_3_1_22_2","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1038\/ng.859","article-title":"Identification of common variants influencing risk of the tauopathy progressive supranuclear palsy","volume":"43","author":"H\u00f6glinger GU","year":"2011","unstructured":"H\u00f6glinger GU Melhem NM Dickson DW Identification of common variants influencing risk of the tauopathy progressive supranuclear palsy. Nat Genet 2011;43(7):699\u2013705. doi:10.1038\/ng.859.","journal-title":"Nat Genet"},{"issue":"12","key":"e_1_3_1_23_2","doi-asserted-by":"crossref","first-page":"2050","DOI":"10.1212\/01.WNL.0000165960.04422.D0","article-title":"New and reliable MRI diagnosis for progressive supranuclear palsy","volume":"64","author":"Oba H","year":"2005","unstructured":"Oba H Yagishita A Terada H New and reliable MRI diagnosis for progressive supranuclear palsy. Neurology 2005;64(12):2050\u20132055. doi:10.1212\/01.WNL.0000165960.04422.D0.","journal-title":"Neurology"},{"issue":"2","key":"e_1_3_1_24_2","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1002\/mds.23293","article-title":"MRI measurements of brainstem structures in patients with Richardson\u2019s syndrome, progressive supranuclear palsy-parkinsonism, and Parkinson\u2019s disease","volume":"26","author":"Longoni G","year":"2011","unstructured":"Longoni G Agosta F Kosti\u0107 VS MRI measurements of brainstem structures in patients with Richardson\u2019s syndrome, progressive supranuclear palsy-parkinsonism, and Parkinson\u2019s disease. Mov Disord 2011;26(2):247\u2013255. doi:10.1002\/mds.23293.","journal-title":"Mov Disord"},{"issue":"9","key":"e_1_3_1_25_2","doi-asserted-by":"crossref","first-page":"1232","DOI":"10.1002\/mds.23054","article-title":"In vivo demonstration of microstructural brain pathology in progressive supranuclear palsy: a DTI study using TBSS","volume":"25","author":"Knake S","year":"2010","unstructured":"Knake S Belke M Menzler K In vivo demonstration of microstructural brain pathology in progressive supranuclear palsy: a DTI study using TBSS. Mov Disord 2010;25(9):1232\u20131238. doi:10.1002\/mds.23054.","journal-title":"Mov Disord"},{"issue":"14","key":"e_1_3_1_26_2","doi-asserted-by":"crossref","first-page":"e60","DOI":"10.1212\/WNL.0b013e3181d7d871","article-title":"Teaching NeuroImages: FDG-PET in progressive supranuclear palsy","volume":"74","author":"Renard D","year":"2010","unstructured":"Renard D Collombier L Castelnovo G Labauge P. Teaching NeuroImages: FDG-PET in progressive supranuclear palsy. Neurology 2010;74(14):e60. doi:10.1212\/WNL.0b013e3181d7d871.","journal-title":"Neurology"},{"issue":"11","key":"e_1_3_1_27_2","doi-asserted-by":"crossref","first-page":"4365","DOI":"10.1021\/jm5017544","article-title":"Tau positron emission tomography (PET) imaging: past, present, and future","volume":"58","author":"Ariza M","year":"2015","unstructured":"Ariza M Kolb HC Moechars D Tau positron emission tomography (PET) imaging: past, present, and future. J Med Chem 2015;58(11):4365\u20134382. doi:10.1021\/jm5017544.","journal-title":"J Med Chem"},{"issue":"2","key":"e_1_3_1_28_2","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1007\/BF00313855","article-title":"The treatment of subacute sclerosing panencephalitis with interferon: a case report","volume":"233","author":"Norris FH","year":"1986","unstructured":"Norris FH Panitch HS Denys EH The treatment of subacute sclerosing panencephalitis with interferon: a case report. J Neurol 1986;233(2):102\u2013107. doi:10.1007\/BF00313855.","journal-title":"J Neurol"},{"issue":"7","key":"e_1_3_1_29_2","doi-asserted-by":"crossref","first-page":"942","DOI":"10.1002\/mds.22023","article-title":"Short-term effects of coenzyme Q10 in progressive supranuclear palsy: a randomized, placebo-controlled trial","volume":"23","author":"Stamelou M","year":"2008","unstructured":"Stamelou M Reuss A Pilatus U Short-term effects of coenzyme Q10 in progressive supranuclear palsy: a randomized, placebo-controlled trial. Mov Disord 2008;23(7):942\u2013949. doi:10.1002\/mds.22023.","journal-title":"Mov Disord"},{"issue":"3","key":"e_1_3_1_30_2","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1016\/j.jocn.2009.05.038","article-title":"The use of zolpidem in the treatment of progressive supranuclear palsy","volume":"17","author":"Cotter C","year":"2010","unstructured":"Cotter C Armytage T Crimmins D. The use of zolpidem in the treatment of progressive supranuclear palsy. J Clin Neurosci 2010;17(3):385\u2013386. doi:10.1016\/j.jocn.2009.05.038.","journal-title":"J Clin Neurosci"},{"issue":"2","key":"e_1_3_1_31_2","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1136\/jnnp.64.2.184","article-title":"Natural history and survival of 14 patients with corticobasal degeneration confirmed at postmortem examination","volume":"64","author":"Wenning GK","year":"1998","unstructured":"Wenning GK Litvan I Jankovic J Natural history and survival of 14 patients with corticobasal degeneration confirmed at postmortem examination. J Neurol Neurosurg Psychiatry 1998;64(2):184\u2013189. doi:10.1136\/jnnp.64.2.184.","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"1","key":"e_1_3_1_32_2","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1212\/WNL.48.1.119","article-title":"Accuracy of the clinical diagnosis of corticobasal degeneration: a clinicopathologic study","volume":"48","author":"Litvan I","year":"1997","unstructured":"Litvan I Agid Y Goetz C Accuracy of the clinical diagnosis of corticobasal degeneration: a clinicopathologic study. Neurology 1997;48(1):119\u2013125. doi:10.1212\/WNL.48.1.119.","journal-title":"Neurology"},{"issue":"11","key":"e_1_3_1_33_2","doi-asserted-by":"crossref","first-page":"1224","DOI":"10.1002\/mds.10536","article-title":"Corticobasal degeneration as a cognitive disorder","volume":"18","author":"Graham NL","year":"2003","unstructured":"Graham NL Bak TH Hodges JR. Corticobasal degeneration as a cognitive disorder. Mov Disord 2003;18(11):1224\u20131232. doi:10.1002\/mds.10536.","journal-title":"Mov Disord"},{"issue":"2","key":"e_1_3_1_34_2","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1136\/jnnp.58.2.174","article-title":"Neuropsychological pattern of striatonigral degeneration: comparison with Parkinson\u2019s disease and progressive supranuclear palsy","volume":"58","author":"Pillon B","year":"1995","unstructured":"Pillon B Gouider-Khouja N Deweer B Neuropsychological pattern of striatonigral degeneration: comparison with Parkinson\u2019s disease and progressive supranuclear palsy. J Neurol Neurosurg Psychiatry 1995;58(2):174\u2013179. doi:10.1136\/jnnp.58.2.174.","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"5","key":"e_1_3_1_35_2","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1212\/WNL.0b013e31827f0fd1","article-title":"Criteria for the diagnosis of corticobasal degeneration","volume":"80","author":"Armstrong MJ","year":"2013","unstructured":"Armstrong MJ Litvan I Lang AE Criteria for the diagnosis of corticobasal degeneration. Neurology 2013;80(5):496\u2013503. doi:10.1212\/WNL.0b013e31827f0fd1.","journal-title":"Neurology"},{"issue":"11","key":"e_1_3_1_36_2","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1093\/jnen\/61.11.935","article-title":"Office of rare diseases neuropathologic criteria for corticobasal degeneration","volume":"61","author":"Dickson DW","year":"2002","unstructured":"Dickson DW Bergeron C Chin SS Office of rare diseases neuropathologic criteria for corticobasal degeneration. J Neuropathol Exp Neurol 2002;61(11):935\u2013946.","journal-title":"J Neuropathol Exp Neurol"},{"issue":"5","key":"e_1_3_1_37_2","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1038\/nrneurol.2011.43","article-title":"Corticobasal degeneration: a pathologically distinct 4R tauopathy","volume":"7","author":"Kouri N","year":"2011","unstructured":"Kouri N Whitwell JL Josephs KA Corticobasal degeneration: a pathologically distinct 4R tauopathy. Nat Rev Neurol 2011;7(5):263\u2013272. doi:10.1038\/nrneurol.2011.43.","journal-title":"Nat Rev Neurol"},{"issue":"21","key":"e_1_3_1_38_2","doi-asserted-by":"crossref","first-page":"1879","DOI":"10.1212\/WNL.0b013e3181feb2e8","article-title":"Imaging correlates of pathology in corticobasal syndrome","volume":"75","author":"Whitwell JL","year":"2010","unstructured":"Whitwell JL Jack CRJr Boeve BF Imaging correlates of pathology in corticobasal syndrome. Neurology 2010;75(21):1879\u20131887. doi:10.1212\/WNL.0b013e3181feb2e8.","journal-title":"Neurology"},{"issue":"1","key":"e_1_3_1_39_2","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/alzrt231","article-title":"Clinicopathologic assessment and imaging of tauopathies in neurodegenerative dementias","volume":"6","author":"Murray ME","year":"2014","unstructured":"Murray ME Kouri N Lin WL Clinicopathologic assessment and imaging of tauopathies in neurodegenerative dementias. Alzheimers Res Ther 2014;6(1):1. doi:10.1186\/alzrt231.","journal-title":"Alzheimers Res Ther"},{"issue":"12","key":"e_1_3_1_40_2","doi-asserted-by":"crossref","first-page":"1172","DOI":"10.1016\/S1474-4422(09)70288-1","article-title":"Multiple system atrophy: an update","volume":"8","author":"Stefanova N","year":"2009","unstructured":"Stefanova N B\u00fccke P Duerr S Wenning GK. Multiple system atrophy: an update. Lancet Neurol 2009;8(12):1172\u20131178. doi:10.1016\/S1474-4422(09)70288-1.","journal-title":"Lancet Neurol"},{"issue":"8","key":"e_1_3_1_41_2","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1002\/mds.21992","article-title":"Red flags for multiple system atrophy","volume":"23","author":"K\u00f6llensperger M","year":"2008","unstructured":"K\u00f6llensperger M Geser F Seppi K Red flags for multiple system atrophy. Mov Disord 2008;23(8):1093\u20131099. doi:10.1002\/mds.21992.","journal-title":"Mov Disord"},{"issue":"4","key":"e_1_3_1_42_2","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1016\/S1474-4422(12)70022-4","article-title":"Premotor signs and symptoms of multiple system atrophy","volume":"11","author":"Jecmenica-Lukic M","year":"2012","unstructured":"Jecmenica-Lukic M Poewe W Tolosa E Wenning GK. Premotor signs and symptoms of multiple system atrophy. Lancet Neurol 2012;11(4):361\u2013368. doi:10.1016\/S1474-4422(12)70022-4.","journal-title":"Lancet Neurol"},{"issue":"15","key":"e_1_3_1_43_2","doi-asserted-by":"crossref","first-page":"2604","DOI":"10.1002\/mds.23192","article-title":"Presentation, diagnosis, and management of multiple system atrophy in Europe: final analysis of the European multiple system atrophy registry","volume":"25","author":"K\u00f6llensperger M","year":"2010","unstructured":"K\u00f6llensperger M Geser F Ndayisaba JP Presentation, diagnosis, and management of multiple system atrophy in Europe: final analysis of the European multiple system atrophy registry. Mov Disord 2010;25(15):2604\u20132612. doi:10.1002\/mds.23192.","journal-title":"Mov Disord"},{"issue":"8","key":"e_1_3_1_44_2","doi-asserted-by":"crossref","first-page":"2382","DOI":"10.1093\/brain\/awq158","article-title":"Cognitive impairment in patients with multiple system atrophy and progressive supranuclear palsy","volume":"133","author":"Brown RG","year":"2010","unstructured":"Brown RG Lacomblez L Landwehrmeyer BG Cognitive impairment in patients with multiple system atrophy and progressive supranuclear palsy. Brain 2010;133(pt 8):2382\u20132393. doi:10.1093\/brain\/awq158.","journal-title":"Brain"},{"issue":"1","key":"e_1_3_1_45_2","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1111\/j.1365-2990.2011.01234.x","article-title":"The neuropathology, pathophysiology and genetics of multiple system atrophy","volume":"38","author":"Ahmed Z","year":"2012","unstructured":"Ahmed Z Asi YT Sailer A The neuropathology, pathophysiology and genetics of multiple system atrophy. Neuropathol Appl Neurobiol 2012;38(1):4\u201324. doi:10.1111\/j.1365-2990.2011.01234.x.","journal-title":"Neuropathol Appl Neurobiol"},{"issue":"2","key":"e_1_3_1_46_2","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1007\/s00401-004-0935-y","article-title":"The role of alpha-synuclein in the pathogenesis of multiple system atrophy","volume":"109","author":"Wenning GK","year":"2005","unstructured":"Wenning GK Jellinger KA. The role of alpha-synuclein in the pathogenesis of multiple system atrophy. Acta Neuropathol 2005;109(2):129\u2013140. doi:10.1007\/s00401-004-0935-y.","journal-title":"Acta Neuropathol"},{"issue":"1","key":"e_1_3_1_47_2","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1002\/mds.24000","article-title":"Dopamine transporter imaging in autopsy-confirmed Parkinson\u2019s disease and multiple system atrophy","volume":"27","author":"Perju-Dumbrava LD","year":"2012","unstructured":"Perju-Dumbrava LD Kovacs GG Pirker S Dopamine transporter imaging in autopsy-confirmed Parkinson\u2019s disease and multiple system atrophy. Mov Disord 2012;27(1):65\u201371. doi:10.1002\/mds.24000.","journal-title":"Mov Disord"},{"issue":"12","key":"e_1_3_1_48_2","doi-asserted-by":"crossref","first-page":"1863","DOI":"10.1212\/01.wnl.0000187889.17253.b1","article-title":"Diagnosis and management of dementia with Lewy bodies: third report of the DLB Consortium","volume":"65","author":"McKeith IG","year":"2005","unstructured":"McKeith IG Dickson DW Lowe J Diagnosis and management of dementia with Lewy bodies: third report of the DLB Consortium. Neurology 2005;65(12):1863\u20131872. doi:10.1212\/01.wnl.0000187889.17253.b1.","journal-title":"Neurology"},{"issue":"8","key":"e_1_3_1_49_2","doi-asserted-by":"crossref","first-page":"1074","DOI":"10.1001\/archneur.65.8.1074","article-title":"Incidental Lewy body disease and preclinical Parkinson disease","volume":"65","author":"DelleDonne A","year":"2008","unstructured":"DelleDonne A Klos KJ Fujishiro H Incidental Lewy body disease and preclinical Parkinson disease. Arch Neurol 2008;65(8):1074\u20131080. doi:10.1001\/archneur.65.8.1074.","journal-title":"Arch Neurol"},{"issue":"10","key":"e_1_3_1_50_2","doi-asserted-by":"crossref","first-page":"1916","DOI":"10.1212\/WNL.54.10.1916","article-title":"Alpha-synuclein cortical Lewy bodies correlate with dementia in Parkinson\u2019s disease","volume":"54","author":"Hurtig HI","year":"2000","unstructured":"Hurtig HI Trojanowski JQ Galvin J Alpha-synuclein cortical Lewy bodies correlate with dementia in Parkinson\u2019s disease. Neurology 2000;54(10):1916\u20131921. doi:10.1212\/WNL.54.10.1916.","journal-title":"Neurology"},{"issue":"8","key":"e_1_3_1_51_2","doi-asserted-by":"crossref","first-page":"1404","DOI":"10.1212\/01.WNL.0000158422.41380.82","article-title":"Cognitive status correlates with neuropathologic stage in Parkinson disease","volume":"64","author":"Braak H","year":"2005","unstructured":"Braak H R\u00fcb U Jansen Steur EN Cognitive status correlates with neuropathologic stage in Parkinson disease. Neurology 2005;64(8):1404\u20131410. doi:10.1212\/01.WNL.0000158422.41380.82.","journal-title":"Neurology"},{"issue":"5","key":"e_1_3_1_52_2","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1002\/gps.2749","article-title":"Biomarkers in dementia with Lewy bodies: a review","volume":"27","author":"Sinha N","year":"2012","unstructured":"Sinha N Firbank M O\u2019Brien JT. Biomarkers in dementia with Lewy bodies: a review. Int J Geriatr Psychiatry 2012;27(5):443\u2013453. doi:10.1002\/gps.2749.","journal-title":"Int J Geriatr Psychiatry"},{"issue":"9","key":"e_1_3_1_53_2","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1212\/WNL.0000000000000734","article-title":"Dementia with Lewy bodies: basis of cingulate island sign","volume":"83","author":"Graff-Radford J","year":"2014","unstructured":"Graff-Radford J Murray ME Lowe VJ Dementia with Lewy bodies: basis of cingulate island sign. Neurology 2014;83(9):801\u2013809. doi: 10.1212\/WNL.0000000000000734.","journal-title":"Neurology"},{"issue":"12","key":"e_1_3_1_54_2","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1212\/01.wnl.0000326146.60732.d6","article-title":"Imaging amyloid deposition in Lewy body diseases","volume":"71","author":"Gomperts SN","year":"2008","unstructured":"Gomperts SN Rentz DM Moran E Imaging amyloid deposition in Lewy body diseases. Neurology 2008;71(12):903\u2013910. doi:10.1212\/01.wnl.0000326146.60732.d6.","journal-title":"Neurology"},{"issue":"7","key":"e_1_3_1_55_2","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1007\/s00702-004-0235-7","article-title":"Follow-up investigations in cerebrospinal fluid of patients with dementia with Lewy bodies and Alzheimer\u2019s disease","volume":"112","author":"Mollenhauer B","year":"2005","unstructured":"Mollenhauer B Bibl M Trenkwalder C Follow-up investigations in cerebrospinal fluid of patients with dementia with Lewy bodies and Alzheimer\u2019s disease. J Neural Transm (Vienna) 2005;112(7):933\u2013948. doi:10.1007\/s00702-004-0235-7.","journal-title":"J Neural Transm (Vienna)"},{"issue":"3","key":"e_1_3_1_56_2","doi-asserted-by":"crossref","first-page":"e91545","DOI":"10.1371\/journal.pone.0091545","article-title":"An eight-year clinic experience with clozapine use in a Parkinson\u2019s disease clinic setting","volume":"9","author":"Hack N","year":"2014","unstructured":"Hack N Fayad SM Monari EH An eight-year clinic experience with clozapine use in a Parkinson\u2019s disease clinic setting. PloS One 2014;9(3):e91545. doi:10.1371\/journal.pone.0091545.","journal-title":"PloS One"},{"issue":"9916","key":"e_1_3_1_57_2","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1016\/S0140-6736(13)62106-6","article-title":"Pimavanserin for patients with Parkinson\u2019s disease psychosis: a randomised, placebo-controlled phase 3 trial","volume":"383","author":"Cummings J","year":"2014","unstructured":"Cummings J Isaacson S Mills R Pimavanserin for patients with Parkinson\u2019s disease psychosis: a randomised, placebo-controlled phase 3 trial. Lancet 2014;383(9916):533\u2013540. doi:10.1016\/S0140-6736(13)62106-6.","journal-title":"Lancet"},{"key":"e_1_3_1_58_2","first-page":"CD006504","article-title":"Cholinesterase inhibitors for dementia with Lewy bodies, Parkinson\u2019s disease dementia and cognitive impairment in Parkinson\u2019s disease","volume":"3","author":"Rolinski M","year":"2012","unstructured":"Rolinski M Fox C Maidment I McShane R. Cholinesterase inhibitors for dementia with Lewy bodies, Parkinson\u2019s disease dementia and cognitive impairment in Parkinson\u2019s disease. Cochrane Database Syst Rev 2012;3:CD006504. doi:10.1002\/14651858.CD006504.pub2.","journal-title":"Cochrane Database Syst Rev"},{"issue":"10","key":"e_1_3_1_59_2","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1016\/S1474-4422(10)70194-0","article-title":"Memantine for patients with Parkinson\u2019s disease dementia or dementia with Lewy bodies: a randomised, double-blind, placebo-controlled trial","volume":"9","author":"Emre M","year":"2010","unstructured":"Emre M Tsolaki M Bonuccelli U Memantine for patients with Parkinson\u2019s disease dementia or dementia with Lewy bodies: a randomised, double-blind, placebo-controlled trial. Lancet Neurol 2010;9(10):969\u2013977. doi:10.1016\/S1474-4422(10)70194-0.","journal-title":"Lancet Neurol"}],"container-title":["Continuum"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/00132979-201608000-00010","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,10]],"date-time":"2025-07-10T14:07:38Z","timestamp":1752156458000},"score":1,"resource":{"primary":{"URL":"https:\/\/continuum.aan.com\/doi\/10.1212\/CON.0000000000000348"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,8]]},"references-count":58,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2016,8]]}},"alternative-id":["10.1212\/CON.0000000000000348"],"URL":"https:\/\/doi.org\/10.1212\/con.0000000000000348","relation":{},"ISSN":["1080-2371","1538-6899"],"issn-type":[{"value":"1080-2371","type":"print"},{"value":"1538-6899","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,8]]}}}